Technical Analysis for TARA - ArTara Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 3.71 | 11.08% | 0.37 |
TARA closed up 11.08 percent on Wednesday, May 15, 2024, on 3.15 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 50 DMA | Bullish | 0.00% | |
| Expansion Pivot Buy Setup | Bullish Swing Setup | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Stochastic Reached Overbought | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 8 hours ago |
| 3x Volume Pace | about 12 hours ago |
| Gap Up Closed | about 12 hours ago |
| Fell Below Upper Bollinger Band | about 12 hours ago |
| Possible Pocket Pivot | about 13 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
ArTara Therapeutics, Inc., a clinical-stage company, develops product candidates for patients suffering from rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. The company's lead program is TARA-002, a cellular therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. ArTara Therapeutics, Inc. is based in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Keywords: Rare Diseases Gastrointestinal Vitamins Chloride Lipid Liver Disease Hepatology Metabolic Disorders Choline Connective Tissue Cholinergics Treatment Of Rare Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Rare Diseases Gastrointestinal Vitamins Chloride Lipid Liver Disease Hepatology Metabolic Disorders Choline Connective Tissue Cholinergics Treatment Of Rare Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.24 |
| 52 Week Low | 1.04 |
| Average Volume | 414,060 |
| 200-Day Moving Average | 2.43 |
| 50-Day Moving Average | 3.40 |
| 20-Day Moving Average | 3.00 |
| 10-Day Moving Average | 3.07 |
| Average True Range | 0.32 |
| RSI (14) | 66.78 |
| ADX | 32.31 |
| +DI | 28.13 |
| -DI | 7.55 |
| Chandelier Exit (Long, 3 ATRs) | 2.83 |
| Chandelier Exit (Short, 3 ATRs) | 3.57 |
| Upper Bollinger Bands | 3.44 |
| Lower Bollinger Band | 2.55 |
| Percent B (%b) | 1.3 |
| BandWidth | 29.92 |
| MACD Line | 0.00 |
| MACD Signal Line | -0.11 |
| MACD Histogram | 0.1034 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.42 | ||||
| Resistance 3 (R3) | 4.36 | 4.08 | 4.30 | ||
| Resistance 2 (R2) | 4.08 | 3.90 | 4.10 | 4.26 | |
| Resistance 1 (R1) | 3.89 | 3.79 | 3.99 | 3.95 | 4.22 |
| Pivot Point | 3.61 | 3.61 | 3.65 | 3.63 | 3.61 |
| Support 1 (S1) | 3.42 | 3.43 | 3.52 | 3.48 | 3.20 |
| Support 2 (S2) | 3.14 | 3.32 | 3.16 | 3.16 | |
| Support 3 (S3) | 2.95 | 3.14 | 3.12 | ||
| Support 4 (S4) | 3.01 |
